Related Experiment Video
Updated: Mar 6, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Impact of haemostatic mechanisms on pathophysiology of preeclampsia
1Haemostasis Research Unit, Department of Haematology, University College London, United Kingdom.
Insights
Preeclampsia, a pregnancy disorder, involves placental tissue factor and PAR-1. Understanding these may lead to new treatments for hypertension and proteinuria in pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Cardiovascular Research
- Hematology
Background:
- Preeclampsia (PE) is characterized by new-onset hypertension and proteinuria in late pregnancy.
- Evidence suggests placental overexpression of tissue factor and PAR-1 contributes to PE pathophysiology.
- Platelet, neutrophil, and complement system activation may also play a role in placental pathology and maternal endothelial dysfunction.
Purpose of the Study:
- To explore the role of placental tissue factor and PAR-1 in preeclampsia.
- To investigate the contribution of excessive cellular activation to PE pathology.
- To identify potential new therapeutic targets for preeclampsia.
Main Methods:
- Review of existing evidence on tissue factor and PAR-1 in PE.
- Analysis of studies on platelet, neutrophil, and complement activation in PE.
- Synthesis of findings to understand the pathophysiology of PE.
Main Results:
- Placental overexpression of tissue factor and PAR-1 is increasingly implicated in PE.
- Excessive activation of platelets, neutrophils, and the complement system are potential contributors to PE.
- Current knowledge highlights complex interactions in PE development.
Conclusions:
- Understanding the molecular mechanisms of PE, including tissue factor and PAR-1, is crucial.
- Further research into cellular activation pathways may reveal novel therapeutic strategies.
- Targeting placental and systemic inflammation could offer new treatment avenues for preeclampsia.
Abstract:
Preeclampsia (PE) is disorder of new onset hypertension and proteinuria during the second half of pregnancy. There is increasing evidence to implicate placental over-expression of tissue factor and PAR-1 in the pathophysiology of PE. Excessive activation of platelets, neutrophils and the complement system may also contribute to the placental pathology and maternal endothelial responsible for the symptoms of PE. Increased knowledge in this field may identify new therapeutic strategies for the treatment of PE.
More Related Videos
12:17The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Hormonal Regulation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Hypertension II: Pathophysiology
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...